| Abstrakt: |
Background: Placenta previa contributes substantial maternal and neonatal morbidity including management challenges for obstetrician. This study was to evaluate the potential risks factors and feto-maternal, outcome in placenta previa. This study was conducted to assess maternal and fetal outcome associated with placenta previa Methods: The present prospective observational study was conducted in the Department of Obstetrics and Gynaecology, Burdwan Medical College and Hospital, Burdwan, West Bengal, India between March 2021 to February 2023. Total 240 cases of placenta previa confirmed after 28 weeks POG were included in the study. Statistical data were analysed by using Microsoft Excel and SPSS V.20 software. Results: We found that out of total 240 cases, 172 (71.67%) were multigravida, 68 (28.33%) were primigravida, and 118 (49.17%) were >31 years of age. In the present study 52 (21.67%) patients were anaemic, 36 (15%) patients had hypothyroidism. In the present study 44 (18.33%) patients were <34 POG, 68 (28.33%) patients 34-37 POG. In the obstetric morbidity 108 (45%) patients required blood transfusions, 24 (10%) required hysterectomy later and 36 (15%) required ICU admission. In the study 12 (5%) neonates required ARDS, NICU admission, 12 (5%) required Birth asphyxia, NICU admission, 6 (2%) suffered from Congenital anomaly, Early neonatal death was 12 (5%), Good APGAR score was among 96 (40%), Low APGAR score, NICU admission was required to 78 (33%) neonates and still birth was 24 (10%) Conclusion: All cases of placenta previa need to be managed in a higher centre with facility of blood component therapy and neonatal intensive care unit. Prematurity and low birth weight remain a significant cause for neonatal morbidity. [ABSTRACT FROM AUTHOR] |
